1Rampaul RS, Miremadi A, Pinder SE, et al. Pathological validation and significance of micrometastasis in sentinel nodes in primary breast cancer[J]. Breast Cancer Res, 2001, 3(2):113 - 116.
2Medina-Franco H, Urist MM. Occult breast carcinoma presenting with axiUary lymph node metastases[J]. Rev Invest Clin, 2002,54(3): 204 -208.
3Kataoka A, Mori M, Sadanaga N, et al. RT-PCR detection of breast cancer cells in sentinel lymph modes[J]. Int J Oncol,2000, 16(6): 1147 - 1152.
4Berois N, Varangot M, Aizen B, et al. Molecular detection of cancer cells in bone marrow and peripheral blood of patients with operable breast cancer. Comparison of CK19, MUC1 and CEA using RT-PCR[J]. Eur J Cancer, 2000, 36(6): 717 - 723.
5Ikeda N, Miyoshi Y, Motomura K, et al. Prognostic significance of occult bone marrow micrometastases of breast cancer detected by quantitative polymerase chain reaction for cytokeratin 19 mRNA[J]. Jpn J Cancer Res, 2000, 91(9): 918 - 924.
6Lockett MA, Baron PL, O'Brien PH, et al. Detection of occult breast cancer micremetastases in axillary lymph nodes using a muhimarker reverse transcfiptase-polymerase chain reaction panel[J]. J Am Coll Surg, 1998, 187(1):9 - 16.
7Peley G, Toth J, Csuka, et al. Immunohistochemistry and reverse transcriptase polymerase chain reaction on sentinel lymph nodes can improve the accuracy of nodal staging in breast cancer patients[J]. Int J Biol Markers, 2001, 16(4): 227 - 232.
8Kohlberger P, Gantert M, Volk-Orlowska T, et al.Immunohistechemical detection of lymph node metastases in node-negative breast cancer patients[J]. Anticancer Res, 2001,21 (1B) : 697 - 699.
9Keene SA, Demeure MJ. The clinical significance of micrometastases and molecular metastases[J]. Surgery, 2001.129(1 ): 1 - 5.
